Prospective evaluation of latent tuberculosis with interferon-gamma release assays in drug and alcohol abusers
- PMID: 19243652
- DOI: 10.1017/S0950268809002131
Prospective evaluation of latent tuberculosis with interferon-gamma release assays in drug and alcohol abusers
Abstract
In vitro tests have been developed for the diagnosis of tuberculosis (TB) infection. The objective was to analyse latent TB infection in drug and alcohol abusers through two interferon-gamma techniques. One hundred and thirty-nine patients were admitted between February 2006 and May 2007. Mean age was 39.8 years [31% HIV positive]. The enzyme immunoassay (EIA) and enzyme-linked immunospot (ELISPOT) interferon-gamma assays were positive in 34% of patients with an agreement of 83% (kappa=0.63). Tuberculin skin test (TST) was positive in 29% of patients and the agreement of TST with EIA and ELISPOT interferon-gamma assays was 85% (kappa=0.62) and 83% (kappa=0.57), respectively. Almost 50% of patients with history of TB had a positive in vitro test. In conclusion, we observed a high prevalence of latent TB and good agreement between the new in vitro tests that otherwise may continue to be positive long after developing TB disease.
Similar articles
-
Usefulness of enzyme-linked immunospot assay (Elispot) compared to tuberculin skin testing for latent tuberculosis screening in rheumatic patients scheduled for anti-tumor necrosis factor treatment.J Rheumatol. 2008 Jul;35(7):1271-6. Epub 2008 Mar 15. J Rheumatol. 2008. PMID: 18381793
-
Tuberculosis infection in drug users: interferon-gamma release assay performance.Int J Tuberc Lung Dis. 2007 Nov;11(11):1183-9. Int J Tuberc Lung Dis. 2007. PMID: 17958979
-
Interferon gamma, interferon-gamma-induced-protein 10, and tuberculin responses of children at high risk of tuberculosis infection.Pediatr Infect Dis J. 2008 Dec;27(12):1073-7. doi: 10.1097/INF.0b013e31817d05a3. Pediatr Infect Dis J. 2008. PMID: 18946366
-
Interferon-gamma release assays and TB diagnosis.Drug Ther Bull. 2009 Jun;47(6):67-70. doi: 10.1136/dtb.2009.05.0021. Drug Ther Bull. 2009. PMID: 19494343 Review.
-
Clinical utility of interferon gamma assay in the diagnosis of tuberculosis.J Am Board Fam Med. 2007 Nov-Dec;20(6):540-7. doi: 10.3122/jabfm.2007.06.070109. J Am Board Fam Med. 2007. PMID: 17954861 Review.
Cited by
-
IFN-γ response on T-cell based assays in HIV-infected patients for detection of tuberculosis infection.BMC Infect Dis. 2010 Dec 10;10:348. doi: 10.1186/1471-2334-10-348. BMC Infect Dis. 2010. PMID: 21143955 Free PMC article.
-
Comparison of two interferon-gamma release assays (QuantiFERON-TB Gold In-Tube and T-SPOT.TB) in testing for latent tuberculosis infection among HIV-infected adults.Int J STD AIDS. 2013 Oct;24(10):775-9. doi: 10.1177/0956462413486459. Epub 2013 Jul 15. Int J STD AIDS. 2013. PMID: 23970606 Free PMC article.
-
Quantiferon Gold-in-tube assay for TB screening in HIV infected children: influence of quantitative values.BMC Infect Dis. 2014 Sep 23;14:516. doi: 10.1186/1471-2334-14-516. BMC Infect Dis. 2014. PMID: 25248406 Free PMC article.
-
Interferon-Gamma Release Assays versus Tuberculin Skin Testing for the Diagnosis of Latent Tuberculosis Infection: An Overview of the Evidence.Pulm Med. 2013;2013:601737. doi: 10.1155/2013/601737. Epub 2013 Feb 7. Pulm Med. 2013. PMID: 23476763 Free PMC article.
-
Interferon-gamma release assays for the diagnosis of latent tuberculosis infection in HIV-infected individuals: a systematic review and meta-analysis.J Acquir Immune Defic Syndr. 2011 Mar 1;56(3):230-8. doi: 10.1097/QAI.0b013e31820b07ab. J Acquir Immune Defic Syndr. 2011. PMID: 21239993 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical